nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2E1—liver cancer	0.4	1	CbGaD
Selegiline—CYP2B6—Sorafenib—liver cancer	0.0521	0.161	CbGbCtD
Selegiline—CYP2C8—Sorafenib—liver cancer	0.0395	0.122	CbGbCtD
Selegiline—CYP2C19—Sorafenib—liver cancer	0.0331	0.102	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—liver cancer	0.0316	0.0977	CbGbCtD
Selegiline—CYP1A2—Sorafenib—liver cancer	0.0306	0.0944	CbGbCtD
Selegiline—CYP2C9—Sorafenib—liver cancer	0.0275	0.0851	CbGbCtD
Selegiline—ABCB1—Sorafenib—liver cancer	0.0267	0.0826	CbGbCtD
Selegiline—CYP2D6—Sorafenib—liver cancer	0.0252	0.0778	CbGbCtD
Selegiline—ABCB1—Doxorubicin—liver cancer	0.0162	0.0501	CbGbCtD
Selegiline—CYP3A4—Sorafenib—liver cancer	0.016	0.0495	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—liver cancer	0.0153	0.0472	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—liver cancer	0.00971	0.03	CbGbCtD
Selegiline—L-Phenylalanine—TAT—liver cancer	0.00214	0.465	CrCbGaD
Selegiline—Pseudoephedrine—IL2—liver cancer	0.00118	0.256	CrCbGaD
Selegiline—Pseudoephedrine—TNF—liver cancer	0.000398	0.0866	CrCbGaD
Selegiline—Benzyl alcohol—CYP2E1—liver cancer	0.000312	0.0678	CrCbGaD
Selegiline—Benzyl alcohol—CYP1A1—liver cancer	0.000308	0.0669	CrCbGaD
Selegiline—Phenelzine—CYP2E1—liver cancer	0.000264	0.0574	CrCbGaD
Selegiline—Cardiac arrest—Epirubicin—liver cancer	0.000216	0.00127	CcSEcCtD
Selegiline—Hypoglycaemia—Doxorubicin—liver cancer	0.000216	0.00127	CcSEcCtD
Selegiline—Mood swings—Epirubicin—liver cancer	0.000216	0.00127	CcSEcCtD
Selegiline—Lethargy—Doxorubicin—liver cancer	0.000215	0.00126	CcSEcCtD
Selegiline—Pruritus—Sorafenib—liver cancer	0.000214	0.00126	CcSEcCtD
Selegiline—Ataxia—Epirubicin—liver cancer	0.000214	0.00126	CcSEcCtD
Selegiline—Dehydration—Epirubicin—liver cancer	0.000212	0.00124	CcSEcCtD
Selegiline—Hyponatraemia—Doxorubicin—liver cancer	0.000211	0.00124	CcSEcCtD
Selegiline—Diplopia—Doxorubicin—liver cancer	0.000211	0.00124	CcSEcCtD
Selegiline—Pain in extremity—Doxorubicin—liver cancer	0.000211	0.00124	CcSEcCtD
Selegiline—Osteoarthritis—Doxorubicin—liver cancer	0.000211	0.00124	CcSEcCtD
Selegiline—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000211	0.00124	CcSEcCtD
Selegiline—Liver function test abnormal—Epirubicin—liver cancer	0.00021	0.00124	CcSEcCtD
Selegiline—Dry skin—Epirubicin—liver cancer	0.000209	0.00123	CcSEcCtD
Selegiline—Orthostatic hypotension—Epirubicin—liver cancer	0.000208	0.00122	CcSEcCtD
Selegiline—Affect lability—Doxorubicin—liver cancer	0.000207	0.00122	CcSEcCtD
Selegiline—Migraine—Doxorubicin—liver cancer	0.000207	0.00122	CcSEcCtD
Selegiline—Hypokalaemia—Epirubicin—liver cancer	0.000207	0.00122	CcSEcCtD
Selegiline—Diarrhoea—Sorafenib—liver cancer	0.000207	0.00122	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000205	0.00121	CcSEcCtD
Selegiline—Face oedema—Doxorubicin—liver cancer	0.000203	0.0012	CcSEcCtD
Selegiline—Gastritis—Epirubicin—liver cancer	0.000201	0.00118	CcSEcCtD
Selegiline—Muscular weakness—Epirubicin—liver cancer	0.000201	0.00118	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000201	0.00118	CcSEcCtD
Selegiline—Cardiac arrest—Doxorubicin—liver cancer	0.0002	0.00118	CcSEcCtD
Selegiline—Dizziness—Sorafenib—liver cancer	0.0002	0.00118	CcSEcCtD
Selegiline—Mood swings—Doxorubicin—liver cancer	0.0002	0.00117	CcSEcCtD
Selegiline—Ataxia—Doxorubicin—liver cancer	0.000198	0.00116	CcSEcCtD
Selegiline—Asthma—Epirubicin—liver cancer	0.000197	0.00116	CcSEcCtD
Selegiline—Influenza—Epirubicin—liver cancer	0.000197	0.00116	CcSEcCtD
Selegiline—Dysphagia—Epirubicin—liver cancer	0.000197	0.00116	CcSEcCtD
Selegiline—Dehydration—Doxorubicin—liver cancer	0.000196	0.00115	CcSEcCtD
Selegiline—Eosinophilia—Epirubicin—liver cancer	0.000195	0.00115	CcSEcCtD
Selegiline—Liver function test abnormal—Doxorubicin—liver cancer	0.000194	0.00114	CcSEcCtD
Selegiline—Dry skin—Doxorubicin—liver cancer	0.000193	0.00114	CcSEcCtD
Selegiline—Vomiting—Sorafenib—liver cancer	0.000192	0.00113	CcSEcCtD
Selegiline—Orthostatic hypotension—Doxorubicin—liver cancer	0.000192	0.00113	CcSEcCtD
Selegiline—Hypokalaemia—Doxorubicin—liver cancer	0.000192	0.00113	CcSEcCtD
Selegiline—Angina pectoris—Epirubicin—liver cancer	0.000192	0.00113	CcSEcCtD
Selegiline—Rash—Sorafenib—liver cancer	0.000191	0.00112	CcSEcCtD
Selegiline—Dermatitis—Sorafenib—liver cancer	0.000191	0.00112	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00019	0.00112	CcSEcCtD
Selegiline—Headache—Sorafenib—liver cancer	0.00019	0.00112	CcSEcCtD
Selegiline—Bronchitis—Epirubicin—liver cancer	0.000189	0.00111	CcSEcCtD
Selegiline—Gastritis—Doxorubicin—liver cancer	0.000186	0.0011	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000186	0.00109	CcSEcCtD
Selegiline—Muscular weakness—Doxorubicin—liver cancer	0.000186	0.00109	CcSEcCtD
Selegiline—Dysuria—Epirubicin—liver cancer	0.000184	0.00108	CcSEcCtD
Selegiline—Dysphagia—Doxorubicin—liver cancer	0.000182	0.00107	CcSEcCtD
Selegiline—Asthma—Doxorubicin—liver cancer	0.000182	0.00107	CcSEcCtD
Selegiline—Influenza—Doxorubicin—liver cancer	0.000182	0.00107	CcSEcCtD
Selegiline—Pollakiuria—Epirubicin—liver cancer	0.000182	0.00107	CcSEcCtD
Selegiline—Eosinophilia—Doxorubicin—liver cancer	0.00018	0.00106	CcSEcCtD
Selegiline—Nausea—Sorafenib—liver cancer	0.00018	0.00106	CcSEcCtD
Selegiline—Photosensitivity reaction—Epirubicin—liver cancer	0.00018	0.00106	CcSEcCtD
Selegiline—Weight increased—Epirubicin—liver cancer	0.000179	0.00105	CcSEcCtD
Selegiline—Weight decreased—Epirubicin—liver cancer	0.000178	0.00105	CcSEcCtD
Selegiline—Hyperglycaemia—Epirubicin—liver cancer	0.000177	0.00104	CcSEcCtD
Selegiline—Angina pectoris—Doxorubicin—liver cancer	0.000177	0.00104	CcSEcCtD
Selegiline—Pneumonia—Epirubicin—liver cancer	0.000176	0.00104	CcSEcCtD
Selegiline—Drowsiness—Epirubicin—liver cancer	0.000175	0.00103	CcSEcCtD
Selegiline—Bronchitis—Doxorubicin—liver cancer	0.000175	0.00103	CcSEcCtD
Selegiline—Neuropathy peripheral—Epirubicin—liver cancer	0.000172	0.00101	CcSEcCtD
Selegiline—Stomatitis—Epirubicin—liver cancer	0.000171	0.00101	CcSEcCtD
Selegiline—Conjunctivitis—Epirubicin—liver cancer	0.000171	0.001	CcSEcCtD
Selegiline—Urinary tract infection—Epirubicin—liver cancer	0.000171	0.001	CcSEcCtD
Selegiline—Dysuria—Doxorubicin—liver cancer	0.00017	0.001	CcSEcCtD
Selegiline—Sweating—Epirubicin—liver cancer	0.000168	0.000989	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—liver cancer	0.000168	0.000989	CcSEcCtD
Selegiline—Haematuria—Epirubicin—liver cancer	0.000167	0.000984	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—liver cancer	0.000166	0.000977	CcSEcCtD
Selegiline—Hepatobiliary disease—Epirubicin—liver cancer	0.000166	0.000976	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—liver cancer	0.000166	0.000974	CcSEcCtD
Selegiline—Epistaxis—Epirubicin—liver cancer	0.000165	0.000973	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—liver cancer	0.000165	0.000968	CcSEcCtD
Selegiline—Sinusitis—Epirubicin—liver cancer	0.000165	0.000968	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—liver cancer	0.000164	0.000966	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—liver cancer	0.000163	0.00096	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—liver cancer	0.000162	0.000954	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—liver cancer	0.00016	0.000943	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—liver cancer	0.000159	0.000936	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—liver cancer	0.000158	0.00093	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—liver cancer	0.000158	0.000928	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—liver cancer	0.000158	0.000928	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—liver cancer	0.000158	0.000928	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—liver cancer	0.000157	0.000926	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—liver cancer	0.000157	0.000921	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—liver cancer	0.000156	0.000919	CcSEcCtD
Selegiline—Sweating—Doxorubicin—liver cancer	0.000156	0.000915	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—liver cancer	0.000156	0.000915	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—liver cancer	0.000155	0.000912	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—liver cancer	0.000155	0.00091	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—liver cancer	0.000154	0.000908	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—liver cancer	0.000154	0.000903	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—liver cancer	0.000153	0.0009	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—liver cancer	0.000152	0.000895	CcSEcCtD
Selegiline—Visual impairment—Epirubicin—liver cancer	0.000152	0.000892	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—liver cancer	0.000148	0.000872	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—liver cancer	0.000147	0.000863	CcSEcCtD
Selegiline—Flushing—Epirubicin—liver cancer	0.000146	0.000859	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—liver cancer	0.000146	0.000859	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—liver cancer	0.000146	0.000857	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—liver cancer	0.000145	0.000853	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—liver cancer	0.000145	0.00085	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—liver cancer	0.000144	0.000846	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—liver cancer	0.000144	0.000844	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—liver cancer	0.000143	0.00084	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—liver cancer	0.000143	0.00084	CcSEcCtD
Selegiline—Chills—Epirubicin—liver cancer	0.000141	0.000831	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—liver cancer	0.000141	0.000827	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—liver cancer	0.00014	0.000826	CcSEcCtD
Selegiline—Alopecia—Epirubicin—liver cancer	0.000139	0.000818	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—liver cancer	0.000138	0.000811	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—liver cancer	0.000137	0.000806	CcSEcCtD
Selegiline—Erythema—Epirubicin—liver cancer	0.000137	0.000806	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—liver cancer	0.000136	0.000799	CcSEcCtD
Selegiline—Flushing—Doxorubicin—liver cancer	0.000135	0.000795	CcSEcCtD
Selegiline—Flatulence—Epirubicin—liver cancer	0.000135	0.000794	CcSEcCtD
Selegiline—Tension—Epirubicin—liver cancer	0.000135	0.000791	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—liver cancer	0.000134	0.000789	CcSEcCtD
Selegiline—Nervousness—Epirubicin—liver cancer	0.000133	0.000783	CcSEcCtD
Selegiline—Back pain—Epirubicin—liver cancer	0.000133	0.00078	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—liver cancer	0.000132	0.000777	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—liver cancer	0.000132	0.000775	CcSEcCtD
Selegiline—Chills—Doxorubicin—liver cancer	0.000131	0.000769	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—liver cancer	0.00013	0.000765	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—liver cancer	0.000129	0.00076	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—liver cancer	0.000129	0.000757	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—liver cancer	0.000128	0.000751	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—liver cancer	0.000127	0.000748	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—liver cancer	0.000127	0.000746	CcSEcCtD
Selegiline—Erythema—Doxorubicin—liver cancer	0.000127	0.000746	CcSEcCtD
Selegiline—Anaemia—Epirubicin—liver cancer	0.000127	0.000745	CcSEcCtD
Selegiline—Agitation—Epirubicin—liver cancer	0.000126	0.000741	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—liver cancer	0.000125	0.000735	CcSEcCtD
Selegiline—Tension—Doxorubicin—liver cancer	0.000124	0.000732	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—liver cancer	0.000124	0.00073	CcSEcCtD
Selegiline—Malaise—Epirubicin—liver cancer	0.000124	0.000727	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—liver cancer	0.000123	0.000724	CcSEcCtD
Selegiline—Vertigo—Epirubicin—liver cancer	0.000123	0.000724	CcSEcCtD
Selegiline—Syncope—Epirubicin—liver cancer	0.000123	0.000723	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—liver cancer	0.000123	0.000722	CcSEcCtD
Selegiline—Back pain—Doxorubicin—liver cancer	0.000123	0.000721	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—liver cancer	0.000122	0.000717	CcSEcCtD
Selegiline—Palpitations—Epirubicin—liver cancer	0.000121	0.000712	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—liver cancer	0.00012	0.000709	CcSEcCtD
Selegiline—Cough—Epirubicin—liver cancer	0.00012	0.000703	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—liver cancer	0.00012	0.000703	CcSEcCtD
Selegiline—Convulsion—Epirubicin—liver cancer	0.000119	0.000698	CcSEcCtD
Selegiline—Hypertension—Epirubicin—liver cancer	0.000118	0.000696	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—liver cancer	0.000118	0.000692	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—liver cancer	0.000117	0.000689	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—liver cancer	0.000117	0.000686	CcSEcCtD
Selegiline—Chest pain—Epirubicin—liver cancer	0.000117	0.000686	CcSEcCtD
Selegiline—Myalgia—Epirubicin—liver cancer	0.000117	0.000686	CcSEcCtD
Selegiline—Agitation—Doxorubicin—liver cancer	0.000117	0.000685	CcSEcCtD
Selegiline—Anxiety—Epirubicin—liver cancer	0.000116	0.000684	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000116	0.000682	CcSEcCtD
Selegiline—Discomfort—Epirubicin—liver cancer	0.000115	0.000678	CcSEcCtD
Selegiline—Malaise—Doxorubicin—liver cancer	0.000114	0.000673	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—liver cancer	0.000114	0.000671	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—liver cancer	0.000114	0.00067	CcSEcCtD
Selegiline—Syncope—Doxorubicin—liver cancer	0.000114	0.000669	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—liver cancer	0.000114	0.000668	CcSEcCtD
Selegiline—Confusional state—Epirubicin—liver cancer	0.000113	0.000663	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—liver cancer	0.000112	0.000659	CcSEcCtD
Selegiline—Oedema—Epirubicin—liver cancer	0.000112	0.000658	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—liver cancer	0.000111	0.000656	CcSEcCtD
Selegiline—Infection—Epirubicin—liver cancer	0.000111	0.000654	CcSEcCtD
Selegiline—Cough—Doxorubicin—liver cancer	0.000111	0.000651	CcSEcCtD
Selegiline—Shock—Epirubicin—liver cancer	0.00011	0.000647	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—liver cancer	0.00011	0.000646	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—liver cancer	0.00011	0.000645	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—liver cancer	0.00011	0.000644	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—liver cancer	0.00011	0.000644	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—liver cancer	0.000109	0.000642	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—liver cancer	0.000109	0.000639	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—liver cancer	0.000108	0.000636	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—liver cancer	0.000108	0.000635	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—liver cancer	0.000108	0.000635	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—liver cancer	0.000108	0.000635	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—liver cancer	0.000108	0.000633	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000107	0.000631	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—liver cancer	0.000107	0.000627	CcSEcCtD
Selegiline—Anorexia—Epirubicin—liver cancer	0.000107	0.000627	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—liver cancer	0.000106	0.000621	CcSEcCtD
Selegiline—Hypotension—Epirubicin—liver cancer	0.000105	0.000615	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—liver cancer	0.000104	0.000614	CcSEcCtD
Selegiline—Oedema—Doxorubicin—liver cancer	0.000104	0.000609	CcSEcCtD
Selegiline—Infection—Doxorubicin—liver cancer	0.000103	0.000605	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000102	0.000599	CcSEcCtD
Selegiline—Shock—Doxorubicin—liver cancer	0.000102	0.000599	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—liver cancer	0.000102	0.000597	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—liver cancer	0.000101	0.000596	CcSEcCtD
Selegiline—Insomnia—Epirubicin—liver cancer	0.000101	0.000595	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—liver cancer	0.000101	0.000594	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—liver cancer	0.000101	0.000591	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—liver cancer	0.0001	0.000591	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—liver cancer	0.0001	0.000588	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—liver cancer	9.97e-05	0.000587	CcSEcCtD
Selegiline—Somnolence—Epirubicin—liver cancer	9.95e-05	0.000585	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—liver cancer	9.87e-05	0.00058	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—liver cancer	9.85e-05	0.000579	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—liver cancer	9.73e-05	0.000572	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—liver cancer	9.67e-05	0.000569	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—liver cancer	9.66e-05	0.000568	CcSEcCtD
Selegiline—Fatigue—Epirubicin—liver cancer	9.65e-05	0.000567	CcSEcCtD
Selegiline—Pain—Epirubicin—liver cancer	9.57e-05	0.000563	CcSEcCtD
Selegiline—Constipation—Epirubicin—liver cancer	9.57e-05	0.000563	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.43e-05	0.000555	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—liver cancer	9.36e-05	0.000551	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—liver cancer	9.3e-05	0.000547	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—liver cancer	9.23e-05	0.000543	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—liver cancer	9.22e-05	0.000542	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—liver cancer	9.2e-05	0.000541	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—liver cancer	9.15e-05	0.000538	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—liver cancer	9.11e-05	0.000536	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—liver cancer	9e-05	0.000529	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—liver cancer	8.94e-05	0.000526	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—liver cancer	8.92e-05	0.000525	CcSEcCtD
Selegiline—Urticaria—Epirubicin—liver cancer	8.89e-05	0.000523	CcSEcCtD
Selegiline—Pain—Doxorubicin—liver cancer	8.85e-05	0.000521	CcSEcCtD
Selegiline—Constipation—Doxorubicin—liver cancer	8.85e-05	0.000521	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—liver cancer	8.84e-05	0.00052	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—liver cancer	8.84e-05	0.00052	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—liver cancer	8.53e-05	0.000502	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—liver cancer	8.47e-05	0.000498	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—liver cancer	8.24e-05	0.000485	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—liver cancer	8.22e-05	0.000484	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—liver cancer	8.18e-05	0.000481	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—liver cancer	8.18e-05	0.000481	CcSEcCtD
Selegiline—Asthenia—Epirubicin—liver cancer	8.03e-05	0.000472	CcSEcCtD
Selegiline—Pruritus—Epirubicin—liver cancer	7.92e-05	0.000465	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—liver cancer	7.65e-05	0.00045	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—liver cancer	7.63e-05	0.000448	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—liver cancer	7.43e-05	0.000437	CcSEcCtD
Selegiline—Dizziness—Epirubicin—liver cancer	7.4e-05	0.000435	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—liver cancer	7.32e-05	0.000431	CcSEcCtD
Selegiline—Vomiting—Epirubicin—liver cancer	7.11e-05	0.000418	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—liver cancer	7.08e-05	0.000417	CcSEcCtD
Selegiline—Rash—Epirubicin—liver cancer	7.05e-05	0.000415	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—liver cancer	7.05e-05	0.000414	CcSEcCtD
Selegiline—Headache—Epirubicin—liver cancer	7.01e-05	0.000412	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—liver cancer	6.85e-05	0.000403	CcSEcCtD
Selegiline—Nausea—Epirubicin—liver cancer	6.65e-05	0.000391	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—liver cancer	6.58e-05	0.000387	CcSEcCtD
Selegiline—Rash—Doxorubicin—liver cancer	6.53e-05	0.000384	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—liver cancer	6.52e-05	0.000383	CcSEcCtD
Selegiline—Headache—Doxorubicin—liver cancer	6.49e-05	0.000381	CcSEcCtD
Selegiline—Nausea—Doxorubicin—liver cancer	6.15e-05	0.000362	CcSEcCtD
Selegiline—CYP2D6—Metabolism—ALDOB—liver cancer	1.35e-05	0.000132	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSTP1—liver cancer	1.35e-05	0.000132	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.34e-05	0.000131	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALDOB—liver cancer	1.34e-05	0.000131	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.33e-05	0.00013	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—HMOX1—liver cancer	1.33e-05	0.00013	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP2E1—liver cancer	1.32e-05	0.000129	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CRABP1—liver cancer	1.29e-05	0.000126	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTA4—liver cancer	1.28e-05	0.000125	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CRABP1—liver cancer	1.27e-05	0.000125	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.26e-05	0.000123	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.25e-05	0.000123	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTA2—liver cancer	1.25e-05	0.000122	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.24e-05	0.000121	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSTM1—liver cancer	1.24e-05	0.000121	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYCS—liver cancer	1.23e-05	0.000121	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.22e-05	0.00012	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—HPGDS—liver cancer	1.22e-05	0.00012	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PSMA4—liver cancer	1.22e-05	0.000119	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PSMD10—liver cancer	1.22e-05	0.000119	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.21e-05	0.000119	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GGT1—liver cancer	1.21e-05	0.000118	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GOT1—liver cancer	1.21e-05	0.000118	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYCS—liver cancer	1.21e-05	0.000118	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTA1—liver cancer	1.2e-05	0.000118	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—HPGDS—liver cancer	1.19e-05	0.000117	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NAT2—liver cancer	1.19e-05	0.000117	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GOT2—liver cancer	1.19e-05	0.000116	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GGT1—liver cancer	1.19e-05	0.000116	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GOT1—liver cancer	1.19e-05	0.000116	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CG—liver cancer	1.18e-05	0.000116	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP1A1—liver cancer	1.17e-05	0.000115	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.15e-05	0.000112	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.14e-05	0.000112	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PPARG—liver cancer	1.14e-05	0.000112	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALDOB—liver cancer	1.14e-05	0.000112	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GLUL—liver cancer	1.14e-05	0.000112	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CPT1B—liver cancer	1.14e-05	0.000112	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—HPGDS—liver cancer	1.12e-05	0.00011	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.12e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP2E1—liver cancer	1.12e-05	0.000109	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—HPGDS—liver cancer	1.11e-05	0.000109	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.11e-05	0.000108	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.11e-05	0.000108	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NR1H4—liver cancer	1.1e-05	0.000108	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—MTHFR—liver cancer	1.09e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.09e-05	0.000107	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CRABP1—liver cancer	1.09e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PSMD10—liver cancer	1.09e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PSMA4—liver cancer	1.09e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTP1—liver cancer	1.09e-05	0.000106	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA3—liver cancer	1.08e-05	0.000106	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.08e-05	0.000106	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PPARA—liver cancer	1.07e-05	0.000105	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—HMOX1—liver cancer	1.07e-05	0.000105	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTP1—liver cancer	1.06e-05	0.000104	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PSMA4—liver cancer	1.06e-05	0.000104	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PSMD10—liver cancer	1.06e-05	0.000104	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GOT2—liver cancer	1.06e-05	0.000104	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—HMOX1—liver cancer	1.05e-05	0.000103	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYCS—liver cancer	1.04e-05	0.000102	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CD—liver cancer	1.04e-05	0.000102	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GOT2—liver cancer	1.03e-05	0.000101	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ALB—liver cancer	1.03e-05	0.000101	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GGT1—liver cancer	1.02e-05	0.0001	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GOT1—liver cancer	1.02e-05	0.0001	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.01e-05	9.93e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PSMA4—liver cancer	1e-05	9.81e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PSMD10—liver cancer	1e-05	9.81e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTM1—liver cancer	9.99e-06	9.78e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP2E1—liver cancer	9.96e-06	9.75e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.96e-06	9.75e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PSMA4—liver cancer	9.93e-06	9.72e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PSMD10—liver cancer	9.93e-06	9.72e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA4—liver cancer	9.88e-06	9.68e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.81e-06	9.6e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTM1—liver cancer	9.78e-06	9.58e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GOT2—liver cancer	9.74e-06	9.54e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2E1—liver cancer	9.72e-06	9.52e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GOT2—liver cancer	9.66e-06	9.46e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.64e-06	9.44e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA2—liver cancer	9.63e-06	9.43e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HPGDS—liver cancer	9.52e-06	9.32e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP1A1—liver cancer	9.47e-06	9.27e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.46e-06	9.27e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYCS—liver cancer	9.32e-06	9.13e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA1—liver cancer	9.29e-06	9.1e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP1A1—liver cancer	9.27e-06	9.08e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTP1—liver cancer	9.2e-06	9.01e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CG—liver cancer	9.19e-06	9e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NAT2—liver cancer	9.19e-06	9e-05	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	9.17e-06	8.98e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2E1—liver cancer	9.16e-06	8.97e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GGT1—liver cancer	9.14e-06	8.95e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GOT1—liver cancer	9.14e-06	8.95e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYCS—liver cancer	9.09e-06	8.91e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2E1—liver cancer	9.08e-06	8.89e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—HMOX1—liver cancer	9.07e-06	8.89e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CB—liver cancer	9.07e-06	8.88e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GGT1—liver cancer	8.92e-06	8.74e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GOT1—liver cancer	8.92e-06	8.74e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PPARG—liver cancer	8.87e-06	8.69e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—MTHFR—liver cancer	8.83e-06	8.64e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—liver cancer	8.81e-06	8.63e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALDOB—liver cancer	8.81e-06	8.63e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.79e-06	8.61e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PPARA—liver cancer	8.66e-06	8.48e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—MTHFR—liver cancer	8.65e-06	8.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.62e-06	8.44e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYCS—liver cancer	8.57e-06	8.39e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.51e-06	8.33e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYCS—liver cancer	8.5e-06	8.32e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PSMA4—liver cancer	8.48e-06	8.31e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PSMD10—liver cancer	8.48e-06	8.31e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PPARA—liver cancer	8.48e-06	8.31e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTM1—liver cancer	8.46e-06	8.28e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GOT1—liver cancer	8.41e-06	8.24e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GGT1—liver cancer	8.41e-06	8.24e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CRABP1—liver cancer	8.4e-06	8.23e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GGT1—liver cancer	8.34e-06	8.16e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GOT1—liver cancer	8.34e-06	8.16e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GOT2—liver cancer	8.25e-06	8.08e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—liver cancer	8.21e-06	8.04e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—HMOX1—liver cancer	8.1e-06	7.93e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CD—liver cancer	8.08e-06	7.91e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—liver cancer	8.02e-06	7.85e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP1A1—liver cancer	8.02e-06	7.85e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ALB—liver cancer	7.98e-06	7.81e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—HMOX1—liver cancer	7.91e-06	7.74e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2E1—liver cancer	7.76e-06	7.6e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTP1—liver cancer	7.55e-06	7.4e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTM1—liver cancer	7.55e-06	7.39e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.51e-06	7.36e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—liver cancer	7.49e-06	7.33e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—MTHFR—liver cancer	7.47e-06	7.32e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—HMOX1—liver cancer	7.45e-06	7.3e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—liver cancer	7.42e-06	7.26e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—HMOX1—liver cancer	7.39e-06	7.23e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTM1—liver cancer	7.37e-06	7.21e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HPGDS—liver cancer	7.35e-06	7.19e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PPARA—liver cancer	7.33e-06	7.18e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—liver cancer	7.26e-06	7.11e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYCS—liver cancer	7.26e-06	7.11e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—liver cancer	7.2e-06	7.05e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PPARG—liver cancer	7.16e-06	7.01e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP1A1—liver cancer	7.15e-06	7.01e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GGT1—liver cancer	7.12e-06	6.98e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GOT1—liver cancer	7.12e-06	6.98e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CB—liver cancer	7.04e-06	6.9e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PPARG—liver cancer	7.01e-06	6.87e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP1A1—liver cancer	6.98e-06	6.84e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTM1—liver cancer	6.94e-06	6.8e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTM1—liver cancer	6.88e-06	6.74e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—MTHFR—liver cancer	6.67e-06	6.53e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.59e-06	6.45e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP1A1—liver cancer	6.58e-06	6.44e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PSMD10—liver cancer	6.55e-06	6.41e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PSMA4—liver cancer	6.55e-06	6.41e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PPARA—liver cancer	6.54e-06	6.41e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1A1—liver cancer	6.52e-06	6.39e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CD—liver cancer	6.52e-06	6.38e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—MTHFR—liver cancer	6.51e-06	6.38e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ALB—liver cancer	6.44e-06	6.3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTP1—liver cancer	6.4e-06	6.27e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PPARA—liver cancer	6.39e-06	6.26e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CD—liver cancer	6.39e-06	6.25e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GOT2—liver cancer	6.37e-06	6.24e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HMOX1—liver cancer	6.31e-06	6.18e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ALB—liver cancer	6.3e-06	6.17e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—liver cancer	6.28e-06	6.15e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—MTHFR—liver cancer	6.14e-06	6.01e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—MTHFR—liver cancer	6.08e-06	5.96e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PPARG—liver cancer	6.06e-06	5.93e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PPARA—liver cancer	6.02e-06	5.89e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2E1—liver cancer	5.99e-06	5.86e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PPARA—liver cancer	5.97e-06	5.84e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTM1—liver cancer	5.88e-06	5.76e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.88e-06	5.76e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CB—liver cancer	5.68e-06	5.57e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—liver cancer	5.6e-06	5.49e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYCS—liver cancer	5.6e-06	5.49e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1A1—liver cancer	5.57e-06	5.46e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CB—liver cancer	5.57e-06	5.45e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—liver cancer	5.53e-06	5.42e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CD—liver cancer	5.52e-06	5.41e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GOT1—liver cancer	5.5e-06	5.38e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GGT1—liver cancer	5.5e-06	5.38e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—liver cancer	5.47e-06	5.36e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALB—liver cancer	5.45e-06	5.34e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PPARG—liver cancer	5.41e-06	5.3e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.36e-06	5.25e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PPARG—liver cancer	5.28e-06	5.17e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—MTHFR—liver cancer	5.2e-06	5.09e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—liver cancer	5.15e-06	5.05e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—liver cancer	5.11e-06	5e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPARA—liver cancer	5.1e-06	4.99e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PPARG—liver cancer	4.97e-06	4.87e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—liver cancer	4.94e-06	4.84e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PPARG—liver cancer	4.93e-06	4.83e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CD—liver cancer	4.93e-06	4.82e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HMOX1—liver cancer	4.87e-06	4.77e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALB—liver cancer	4.86e-06	4.76e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CB—liver cancer	4.81e-06	4.71e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CD—liver cancer	4.81e-06	4.71e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALB—liver cancer	4.75e-06	4.65e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.58e-06	4.49e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTM1—liver cancer	4.54e-06	4.44e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CD—liver cancer	4.53e-06	4.44e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—liver cancer	4.52e-06	4.42e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CD—liver cancer	4.49e-06	4.4e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALB—liver cancer	4.47e-06	4.38e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALB—liver cancer	4.43e-06	4.34e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—liver cancer	4.37e-06	4.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1A1—liver cancer	4.3e-06	4.21e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CB—liver cancer	4.29e-06	4.21e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—liver cancer	4.29e-06	4.2e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPARG—liver cancer	4.21e-06	4.13e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CB—liver cancer	4.19e-06	4.1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MTHFR—liver cancer	4.01e-06	3.93e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CB—liver cancer	3.95e-06	3.87e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPARA—liver cancer	3.94e-06	3.85e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CB—liver cancer	3.92e-06	3.83e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CD—liver cancer	3.84e-06	3.76e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALB—liver cancer	3.79e-06	3.71e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—liver cancer	3.51e-06	3.43e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—liver cancer	3.46e-06	3.39e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—liver cancer	3.39e-06	3.32e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—liver cancer	3.37e-06	3.3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CB—liver cancer	3.35e-06	3.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPARG—liver cancer	3.25e-06	3.19e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CD—liver cancer	2.96e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—liver cancer	2.93e-06	2.87e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALB—liver cancer	2.92e-06	2.86e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—liver cancer	2.83e-06	2.77e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—liver cancer	2.77e-06	2.71e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—liver cancer	2.62e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CB—liver cancer	2.58e-06	2.53e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—liver cancer	2.56e-06	2.5e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—liver cancer	2.41e-06	2.36e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—liver cancer	2.4e-06	2.35e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—liver cancer	2.39e-06	2.34e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—liver cancer	2.14e-06	2.09e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—liver cancer	2.09e-06	2.04e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—liver cancer	2.04e-06	2e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—liver cancer	1.97e-06	1.93e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—liver cancer	1.95e-06	1.91e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—liver cancer	1.67e-06	1.63e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—liver cancer	1.57e-06	1.54e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—liver cancer	1.29e-06	1.26e-05	CbGpPWpGaD
